A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas-Reference-Cited by-同舟云学术

A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas

Published:2013-11-27 Issue:11 Volume:8 Page:e80539
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Imperiale Alessio,Moussallieh François-Marie,Sebag Frédéric,Brunaud Laurent,Barlier Anne,Elbayed Karim,Bachellier Philippe,Goichot Bernard,Pacak Karel,Namer Izzie-Jacques,Taïeb David

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma;M Jafri;Clinical endocrinology,2013

2. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients;V Piccini;Endocr Relat Cancer,2012

3. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma;HJ Timmers;Endocr Relat Cancer,2009

4. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients;H Huang;Cancer,2008

5. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability;JS Isaacs;Cancer Cell,2005

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and proteomics in pheochromocytoma/paraganglioma: translating biochemistry and biology to bedside;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

2. Hypoxic Signaling Pathways in Carotid Body Tumors;Cancers;2024-01-30

3. Imaging of Pheochromocytomas and Paragangliomas;Endocrine Reviews;2024-01-11

4. Metabolomics in paraganglioma: applications and perspectives from genetics to therapy;Endocrine-Related Cancer;2023-03-10

5. Metabolomics and Genetics of Rare Endocrine Disease: Adrenal, Parathyroid Glands, and Cystic Fibrosis;Clinical Metabolomics Applications in Genetic Diseases;2023